Vandetanib for the treatment of medullary thyroid carcinoma.
about
Safe handling of oral antineoplastic medications: focus on targeted therapeutics in the home settingDiagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.Selective use of vandetanib in the treatment of thyroid cancer.Medullary Thyroid Cancer: Clinical Characteristics and New Insights into Therapeutic Strategies Targeting Tyrosine Kinases.The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer.
P2860
Vandetanib for the treatment of medullary thyroid carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Vandetanib for the treatment of medullary thyroid carcinoma.
@en
type
label
Vandetanib for the treatment of medullary thyroid carcinoma.
@en
prefLabel
Vandetanib for the treatment of medullary thyroid carcinoma.
@en
P2093
P2860
P356
P1476
Vandetanib for the treatment of medullary thyroid carcinoma.
@en
P2093
Daniel J Shaheen
Maryann R Cooper
Michael Steinberg
Soo Yun Yi
P2860
P304
P356
10.1177/1060028013512791
P407
P577
2013-11-14T00:00:00Z